Table 3. Results of antibacterial susceptibility tests.
Antibiotic | S (%) | I (%) | R (%)* |
---|---|---|---|
Ampicillin** | 0 (0) | 0 (0) | 12 (100) |
Gentamicin | 12 (100) | 0 (0) | 0 (0) |
Tetracycline | 8 (66) | 1 (8.3) | 3 (25) |
Cefoxitin | 6 (50) | 3 (25) | 3 (25) |
Nalidixic acid | 7 (58.3) | 0 (0) | 5 (41.6) |
Amikacin | 12 (100) | 0 (0) | 0 (0) |
Ceftazidime | 7 (58.3) | 4 (33.3) | 1 (8.3) |
Chloramphenicol | 11 (91.6) | 0 (0) | 1 (8.3) |
TMP-SMX | 5 (41.6) | 2 (16.6) | 5 (41.6) |
Cefotaxime | 8 (66.6) | 2 (16.6) | 2 (16.6) |
Cefepime | 12 (100) | 0 (0) | 0 (0) |
Streptomycin | 7 (58.3) | 3 (25) | 2 (16.6) |
Ciprofloxacin | 9 (75) | 3 (25) | 0 (0) |
I – intermediate; R – resistant; S – sensitive; TMP-SMX – trimethoprim-sulfamethoxazole.
The total sum percentages do not produce 100 in some cases due to decimal rounding.
Ampicillin was included in the growth medium used for culturing the isolates.